in collagenase solution range, or an introduction of collagenase solution to the pancreas after resec tion. 10, 11 In 1967, Lacy and Kostianowski further developed the method of islet isolation by intro ducing collagenase solution to the common bile duct before pancreas resection. 12 This method, with some modifications, has been used for pancreas di gestion and islet isolation until now.
In our laboratory we use the infusion to com mon bile duct 1000 U/ml concentration of collage nase (Boeringher P) and pancreas digestion at 37°C for 10-13 minutes.
Pigs' islet isolation We harvested >300 pancre ases from market slaughterhouses, from pigs weighing 100-250 kg. In the slaughterhouses, the pancreases were dissected ex situ immediate ly after killing and subjected to exsanguination, water (60°C) bathing, and skin shaving (warm ischemia time 15-30 min.). The main pancreat ic duct was cannulated and infused with diges tion medium (depending on the method) at 4°C. The organ was transported (4°C, cold ischemia time >190 min) to the laboratory. Initially, five different methods of pancreas digestion were used (Ricordi, 13, 14 Horaguchi, 15 Ricordi and Hor augouhi, Viviani, 16 our original method 17 ). Cur rently, we use our own solution for islet isola tion: pancreas digestion with digestion medi um in the plastic bottle with or without minimal shaking. Digestion is terminated when free islets are detected under the microscope. After filtra tion across 300µm mesh, the islets are washed, suspended in Hanks's solution, and quantitated. Their number is converted into 150µm diameter islet equivalents (IE). Islets of <50 µm in diame ter are not counted. The viability of islets is con firmed by dithizone staining.
Microencapsulation The aim of our study was to find a practically applicable method to re duce the barrier between encapsulated islets and the bloodstream in order to improve both the functional performance and the survival of encapsulated islet grafts. Microencapsulation was proposed by Sun 18 and has been the most pop ular and modified encapsulation method to date. The idea behind this method is to enclose one is let in a semipermeable membrane. Alginate is the most common and one of the most promis ing bio materials used for encapsulation of alloge neic and xenogeneic cells and tissues (e.g. Langer hans islets). In the alginate system, the process of microcapsule formation involves the gelation of an alginatecell suspension in a calcium chloride bath. Droplets are made using our own impulsed voltage droplet generator designed at the IBBE. 19 Briefly, handpicked islets are suspended in 1 ml of 1.5% (wt/vol) sodium alginate (Sigma, St. Louis, MO, USA) and the droplets formed by the droplet generator are gelled in 1.1% CaCl 2 solution. To im prove the strength of alginate capsules and create a better immunoprotective barrier, several layers of capsule membranes are applied: of these methods find clinical application only in individual cases. 2 Moreover, to protect the al lografts or xenografts against transplant rejection, strong immunosuppressive treatment or, prefer ably, graft immunoisolation are required.
A bio artificial pancreas 3,4 may become a prom ising approach to prevent or reverse complications associated with diabetes. Bioartificial pancreatic constructs are based on islet encapsulation, which involves using an artificial membrane to protect transplanted tissue from the host immune sys tem. Semipermeable membranes used for trans plant immunoprotection must be bio compatible, nondegradable, selectively permeable and resis tant to mechanical stress. They should have ap propriate diffusion properties for oxygen, nutri ents, glucose and cell meta bolic products, and should be impermeable to both the cellular and humoral components of the host immune system. This method eliminates the need for immuno suppressive drugs, and offers a possible solution to the shortage of donors as it may allow the use of animal islets or insulinproducing cells engi neered from stem cells. Extravascular approaches are either macroencapsulation 5,6 (large numbers of islets together in one device, hydrogel matrix or capillary) or microencapsulation 7,8 (envelope for each individual islet in a semipermeable im munoprotective capsule). The microencapsulation approach is quite promising because it shortens the way of diffusion and the transplantation is technically easier than in macroencapsulation.
Both patients and physicians hope for the pos sibility to effectively cure insulindependent di abetes mellitus. It was also the great ambition of Professor Tadeusz Orłowski. In 1982, Profes sor Orłowski was appointed the head of the labo ratory at the Transplantation Institute of the Med ical University of Warsaw and the Institute of Biocybernetics and Biomedical Engineering (IBBE)at the Polish Academy of Sciences.
The laboratory has conducted research on the methods of Langerhans islet isolation from animals including mice, rats, and pigs, and ini tially also from human pancreas. A range of pro cedures for purification of the tissue have been used. Different methods of islet immunoisola tion have been applied and the effect of encapsu lated islets on the host immune system has been investigated. Another area of research has been the cryopreservation of islets to collect a suffi cient number of proper islets for the transplan tation to be successful.
MATERIAL And METhods
Obtaining good islet isolation is one of the most important factors be hind the success of islet transplantation. A suc cessful method of islet isolation was initiated in 1965 by Moskalewski, 9 who suggested the use of collagenase solution for pancreas digestion.
Rat islet isolation Initially, various procedures of islet isolation were applied including mechani cal crumbling of the pancreas, multiple digesting transplantations of 500 nonencapsulated (free islands -FI) or 500 encapsulated by APA mem brane islands (E APA I) and 500 APA capsules. Ten to fourteen days after grafting from immunized mice the splenocytes were obtained for in vitro examination. To observe the immunogenici ty of the transplanted material in vitro, a modi fied classic culture used for studying immunore sponse, the oneway mixed splenocyte and islet culture (MSIC) test, was used. 28, 29 The spleen cells obtained from naïve or xenoim munized recipients were used as responder sple nocytes in the test. The research material was di vided into the following groups: 1 splenocytes received from nonsensitized mice stimulated in test by free islets (C I ), encapsulat ed islets (C EI ) or empty capsules (C APA ), 2 splenocytes isolated from mice immunized by nonencapsulated islets (FI) and encapsulated islets (E APA I) and empty capsules (C APA ).
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MSIC test preparation: as stimulators 20 is lets or 5 × 10 5 splenocytes (nonencapsulated or encapsulated), pretreated with mitomycin C (5 µg/ml; Sigma), were cocultured together with responders 5 × 10 5 splenocytes prepared from na ïve and immunized mice, for 1-5 days at 37°C in 95% humified atmosphere of 5% CO 2 . After 1-5 days of culture [ 3 H] thymidine (0.5 µCi per sample; Świerk, Poland) was added and cells were harvested after 24 hours. Samples were count ed in a scintillation counter. Proliferation of re sponder splenocytes as response to antigen stim ulation was expressed as Stimulation Indices (SI) and calculated as (count per minute [cpm] of re sponder splenocytes + stimulator)-(cpm of stim ulator alone) divided by (cpm of responder sple nocytes alone).
skin grafting To sensitize the immune host the skins were transplanted 30 days before or af ter nonencapsulated or encapsulated rat's WAG islets of Langerhans (TAbLE 1) were transplant ed, and skin graft rejection and glycemia were observed.
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Skin grafting was performed using the meth od of Billingham and Medawar.
33 Fullthick ness skin (1 × 1 cm) from the belly of a donor rat was engrafted onto the right side of the thorax 1 alginateprotamineheparin complex (APH) according to Tatarkiewicz: 20, 21 alginate capsules are exposed successively to 0.25% polyethyle neimine solution, 0.1% protamine sulfate solu tion, and 25 U/ml heparin solution. 2 alginatepoliLlysinealginate (APA) accord ing to Sun: 22 alginate capsules are exposed succes sively to 0.05% poly Llysine (Sigma) and to 0.15% sodium alginate. Finally, alginate gel inside mi crocapsules is liquefied by 0.05 molar sodium citrate. Thus formed microcapsules are spher ical and smooth, with reproducible diameters of 300-500 microns.
biocompatibility and resistance of APh and APA membranes Empty capsules were transplanted into rats under skin, intraperitoneally and under kidney capsule and were observed to be general ly harmless at 1, 2, 3 and 4 months. Histo logical evaluation performed after this time 23,24 dem onstrated that they did not adhere to the neigh boring tissues and were not covered with any fi brous tissue for the both membrane types inves tigated. The empty capsules were tested on resis tance by ultrasonic damage, alkalization, several passages through syringe needles, osmotic stress, and freezing. 25 Cryopreservation The effectiveness of Langer hans islet transplantation in humans is limited due to difficulties in isolating a sufficient num ber of islets from a single donor. Cryopreserva tion enables to collect a sufficient number of islets for transplantation. Islets isolated from the pan creas, nonencapsulated (free -F) or encapsulat ed (E), were cryopreserved using the Rajotte
26,27
method of slow cooling and rapid thawing.
The effect of xenotransplantation of encapsulated islets on the host immune system We evaluated whether xenotransplantation of rat islets encap sulated by APA membrane to mice would specifi cally stimulate the host immune system and ver ified membrane performance in a system with encapsulated material capable of specific stim ulation. The first (control) group of the recipi ents were naïve. The second group of the recipi ents were immunized in vivo by intraperitoneal Cryopreservation After 2-454 days of banking in a frozen state, the islets were thawed. The num ber of viable islets stained with dithizone, and the yield of thawed islets as a percentage of their precryopreservation number were compared. 36 The yield of the thawed encapsulated islets was higher than that of the nonencapsulated islets (E = 83% ±1.3 SE; F = 65% ±8 SE). The thawed encapsulated islets demonstrated better sur vival: E = 90% ±3.5 SE stained with dithizone; F = 70% ±5.1 SE.
Microencapsulation Several features were compa rable in the APH and APA capsules. Both the APH (FIGuRE 2A) and APA (FIGuRE 2b) capsules were spher ical and smooth, with reproducible diameters of approximately 400 µm. Empty APH capsules were stronger than APA (TAbLE 2) . The walls of both capsule types displayed selective permeability. Intraperitoneal transplantation into strepto zotocindiabetic mice of 1000 nonencapsulated rat islets restored normoglycemia for 5-9 days (DI F ). Immunoisolation of islets by encapsula tion before transplantation with APH membrane can reverse hyperglycemia for >6 weeks (46 ±15 days), whereas APAisolated grafts can secrete appropriate amounts of insulin much longer, i.e. more than 180 days (TAbLE 3) .
In vivo, both APH and APA capsules grafted into the peritoneal cavity or under renal capsule provoke no inflammatory reactions and are free from cellular and fibrotic overgrowth. of a recipient mouse. The graft was covered with gauze and plaster that were removed on day 5. Graft were scored daily until rejection (defined as loss of >80% of the graft tissue).
The length of islet graft survival served as a cri terion for the sensitizing capacity of the prima ry graft and membrane protection. According to the design of the performed experiments, mice were classified into the following groups consist ing of 7 animals each: D F S = Skin (S) after nonencapsulated (F) islets transplantation; DE APA S = Skin (S) after encapsulated (E APA ) islets transplantation; DSSI F = nonencapsulated islet transplantation after the second skin transplant; DSSE APA = encapsulated islet transplantation after the second skin transplants.
Xenotransplantation of encapsulated Langerhans
islets One thousand islets: free (group D F ), en capsulated with APA (group DE APA ) or encapsu lated with APH (group DE APH ), were transplant ed intraperitoneally onto streptozotocininduced (intravenously 165 mg/kg body weight) diabetic BALB/c mice. Only mice with 2 consecutive blood glucose levels >350 mg/dl were transplanted. Di abetic mice were used as a control (group D).
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REsuLTs Pig's islet isolation In all specimens, cell groups with diameters <100 µm contained in the nonencapsulated islet group SI (C EI ) <SI (E APA I) <SI (FI). Islet encapsulation reduced their immunogenicity. We didn't observe significant differences af ter stimulation of the responder splenocytes ob tained from mice after immunization with emp ty capsules APA: SI = 2.0 ±0.5 SD was comparable to the control group C APA : SI = 1.59 ±0.54 SD.
APH capsules are more resistant but longterm experiment indicates that immunoisolation with APA microcapsules is more effective than with APH microcapsules.
Microencapsulation sufficiently protected the grafted islets and the remission of diabetes was maintained. Independently of the reason for donor antigen leakage through normal or dam aged capsular wall, encapsulated islet transplant may stimulate the recipient's immune response. Nevertheless, encapsulation sufficiently protects the graft from destruction.
The present results are consistent with the opin ion that encapsulation does not protect the host immune system from stimulation but rather acts as "artificial immunoprivileged site" shielding the graft from destruction. Precryopreservative skin grafting Graft survival times are present ed in TAbLE 3. After islet transplantation (DE APA S group) euglycemia was maintained during the whole period of observation (up to 55 days) even after stimulation of the host by skin grafting. In diabetic recipients strongly stimulated by skin grafts (groups DSSI F and DSSE APA ), subsequent transplantation of encapsulated islets did not re store euglycemia despite encapsulation.
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The influence of xenotransplantation of encapsulated islets on immune system of the host Results are presented in TAbLE 4. After stimulation by nonen capsulated rat islets, strong proliferation of re sponder splenocytes in the MSIC test was ob served C I : SI = 24.5 ±4.6 standard deviation (SD). Splenocyte response to stimulation by encapsulat ed islets was weak C EI : SI = 0.93 ±0.18 SD. Contrary to expectations, after recipient immunization by nonencapsulated islets, the proliferation of re sponder splenocytes was lower than in the con trol group FI: SI = 7.1 ±2.1 SD. Proliferation of re sponder splenocytes, obtained from mice immu nized by encapsulated islets in the MSIC test, was higher than in the control group but lower than Abbreviations: I - islets, S - skin, DES - skin after encapsulated islet transplantation, DSSI - non-encapsulated islet transplantation after two skin transplants, DSSE - encapsulated islet transplantation after two skin transplants, others - see microencapsulation of Langerhans islets improves their yield and function. In the case of free islets, sucrose should be added to cryopreservation for thawing procedure. Transplanted material after encapsulation only slightly influences the prolif eration of the recipient splenocytes.
